Condition
Excessive Diet Restriction
Total Trials
2
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
1 treatments under study, led by Alternate Day Fasting
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Completed2
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (2)
Research Network
Common Treatments
- Alternate Day Fasting1
Active Sponsors
- University of Graz1
- Pennington Biomedical Research Center1
- Medical University of Graz1
Top Investigators
Medical University of Graz, Auenbruggerplatz 15
Medical University Graz, Austria
Pennington Biomedical Research Center
Karl Franzens University Graz, Austria